1.Wong MC, Goggins WB, Wang HH, Fung FD, Leung C, Wong SY, Ng CF, Sung JJ: Global Incidence and Mortality for Prostate Cancer: Analysis of Temporal Patterns and Trends in 36 Countries. Eur Urol 2016, 70(5):862–874.
2.Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Zappa M, Nelen V, Kwiatkowski M, Lujan M, Maattanen L, Lilja H et al: Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. Lancet 2014, 384(9959):2027–2035.
3.Miyoshi Y, Noguchi K, Yanagisawa M, Taguri M, Morita S, Ikeda I, Fujinami K, Miura T, Kobayashi K, Uemura H: Nomogram for overall survival of Japanese patients with bone-metastatic prostate cancer. BMC Cancer 2015, 15:338.
4.Gandaglia G, Karakiewicz PI, Briganti A, Passoni NM, Schiffmann J, Trudeau V, Graefen M, Montorsi F, Sun M: Impact of the Site of Metastases on Survival in Patients with Metastatic Prostate Cancer. Eur Urol 2015, 68(2):325–334.
5.Scher HI, Halabi S, Tannock I, Morris M, Sternberg CN, Carducci MA, Eisenberger MA, Higano C, Bubley GJ, Dreicer R et al: Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group. J Clin Oncol 2008, 26(7):1148–1159.
6.Williams BJ, Fox BD, Sciubba DM, Suki D, Tu SM, Kuban D, Gokaslan ZL, Rhines LD, Rao G: Surgical management of prostate cancer metastatic to the spine. J Neurosurg Spine 2009, 10(5):414–422.
7.Wu AS, Fourney DR: Evolution of treatment for metastatic spine disease. Neurosurg Clin N Am 2004, 15(4):401–411.
8.Byrne TN: Spinal cord compression from epidural metastases. N Engl J Med 1992, 327(9):614–619.
9.Clarke MJ, Molina CA, Fourney DR, Fisher CG, Gokaslan ZL, Schmidt MH, Rhines LD, Fehlings MG, Laufer I, Patel SR et al: Systematic Review of the Outcomes of Surgical Treatment of Prostate Metastases to the Spine. Global Spine J 2017, 7(5):460–468.
10.Patchell RA, Tibbs PA, Regine WF, Payne R, Saris S, Kryscio RJ, Mohiuddin M, Young B: Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 2005, 366(9486):643–648.
11.Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA, Grading C: The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System. Am J Surg Pathol 2016, 40(2):244–252.
12.Soloway MS, Hardeman SW, Hickey D, Raymond J, Todd B, Soloway S, Moinuddin M: Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan. Cancer 1988, 61(1):195–202.
13.Frankel HL, Hancock DO, Hyslop G, Melzak J, Michaelis LS, Ungar GH, Vernon JD, Walsh JJ: The value of postural reduction in the initial management of closed injuries of the spine with paraplegia and tetraplegia. I. Paraplegia 1969, 7(3):179–192.
14.Lawton AJ, Lee KA, Cheville AL, Ferrone ML, Rades D, Balboni TA, Abrahm JL: Assessment and Management of Patients With Metastatic Spinal Cord Compression: A Multidisciplinary Review. J Clin Oncol 2019, 37(1):61–71.
15.Sorensen S, Helweg-Larsen S, Mouridsen H, Hansen HH: Effect of high-dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomised trial. Eur J Cancer 1994, 30A(1):22–27.
16.Cantu RC, Ojemann RG: Corticosteroids in aseptic meningitis. Lancet 1967, 2(7530):1360–1361.
17.Clarke PR, Saunders M: Steroid-induced remission in spinal canal reticulum cell sarcoma. Report of two cases. J Neurosurg 1975, 42(3):346–348.
18.Cheng KH, Mariampillai A, Lee KK, Vuong B, Luk TW, Ramjist J, Curtis A, Jakubovic H, Kertes P, Letarte M et al: Histogram flow mapping with optical coherence tomography for in vivo skin angiography of hereditary hemorrhagic telangiectasia. J Biomed Opt 2014, 19(8):086015.
19.Yamashita T, Aota Y, Kushida K, Murayama H, Hiruma T, Takeyama M, Iwamura Y, Saito T: Changes in physical function after palliative surgery for metastatic spinal tumor: association of the revised Tokuhashi score with neurologic recovery. Spine (Phila Pa 1976) 2008, 33(21):2341–2346.
20.Tokuhashi Y, Matsuzaki H, Oda H, Oshima M, Ryu J: A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine (Phila Pa 1976) 2005, 30(19):2186–2191.
21.Yang YJ, Lin GW, Li GX, Dai B, Ye DW, Wu JL, Xie HY, Zhu Y: External validation and newly development of a nomogram to predict overall survival of abiraterone-treated, castration-resistant patients with metastatic prostate cancer. Asian J Androl 2018, 20(2):184–188.
22.Crnalic S, Hildingsson C, Wikstrom P, Bergh A, Lofvenberg R, Widmark A: Outcome after surgery for metastatic spinal cord compression in 54 patients with prostate cancer. Acta Orthop 2012, 83(1):80–86.
23.Ju DG, Zadnik PL, Groves ML, Hwang L, Kaloostian PE, Wolinksy JP, Witham TF, Bydon A, Gokaslan ZL, Sciubba DM: Factors associated with improved outcomes following decompressive surgery for prostate cancer metastatic to the spine. Neurosurgery 2013, 73(4):657–666; discussion 666.